Statistics
Publications
271
Citations
41.5K
H-Index
83
Active since
1968
John Wilding is an author at University of Liverpool specializing in medicine, pharmacology, and diabetes mellitus.
Publications per year
1968–2025
271
271
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text
A role for glucagon-like peptide-1 in the central regulation of feeding
Mandy D. Turton, Donal O’Shea, I. Gunn et al. · Nature · 1996 · 1.9K citations
1–5 of 271